is a partner at Walder Wyss Ltd. His key practice areas are Swiss and international reimbursement and the pricing law of pharmaceuticals and other therapeutic products, as well as regulatory issues surrounding pharmaceuticals, medical devices, special nutrition, cosmetics, genetic testing, stem cells and blood products. Andreas is widely published on legal issues arising from pharmaceuticals and healthcare.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.